Pharma

Your Article Summary

See Latest Articles

Recommendations for appropriate sublingual immunotherapy clinical trials
Journal of Allergy and Clinical Immunology, 09/23/09

Casale TB et al. – This article reviews data from sublingual immunotherapy trials and makes recommendations about appropriate designs of future sublingual immunotherapy studies. It is hoped that these recommendations will result in more adequately designed sublingual immunotherapy trials to facilitate the appropriate placement of this therapy to treat patients with allergic rhinoconjunctivitis and other allergic diseases.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Primary endpoint reached in Active Biotechs TASQ Phase II clinical trial in prostate cancer patients
Active Biotech, 12/14/09

ARIAD Announces Updated Data from Clinical Trial of Its Investigational mTOR Inhibitor, Ridaforolimus, In Combination with Trastuzumab
ARIAD Pharmaceuticals, 12/14/09

Annual Progression of Coronary Calcification in Trials of Preventive Therapies
Archives of Internal Medicine, 12/14/09

 See all of Drug Trials